Ligand Appoints Martine Zimmermann to its Board of Directors
September 26, 2023 05:05 PM Eastern Daylight Time SAN DIEGO – Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced the appointment of Martine Zimmermann, PharmD, to its Board of Directors as an independent director. Dr. Zimmermann brings 25 years of global experience in the pharmaceutical industry to Ligand’s board. “We are very pleased to welcome Martine to our board of directors. She brings considerable expertise in development and … Continue reading Ligand Appoints Martine Zimmermann to its Board of Directors